Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy

NCT04219826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertrophic Cardiomyopathy (HCM)

Interventions

DRUG: CK-3773274 (5 - 15 mg)
DRUG: CK-3773274 (10 - 30 mg)
DRUG: Placebo for CK-3773274

Sponsor

Cytokinetics